ArticleFrontiers in public health2025
Analysis and prediction of disease burden related to opioid use disorder in China based on GBD 2021.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To analyze the disease burden of opioid use disorder (OUD) in China from 1990 to 2021 and predict its future trends. Methods: Annual data from the Global Burden of Disease (GBD 2021) database were used to describe the disease burden through metrics such as prevalence, incidence, mortality, and disability-adjusted life years (DALYs). Joinpoint regression models were employed to analyze trends in disease burden. The estimated annual percentage change (EAPC) was calculated to quantify the temporal trends in age-standardized rates (ASRs). The age-period-cohort (APC) model explored age, period, and cohort effects on the OUD burden. Health inequality analyses examined the relationship between the OUD burden and the Sociodemographic Index (SDI). The autoregressive integrated moving average (ARIMA) model was used to forecast the OUD disease burden over the next 15 years. Results: Compared to 1990, the OUD-related disease burden in China declined across various indicators by 2021, with a significant decrease in the age-standardized mortality rate (EAPC = -5.26). Meanwhile, the global disease burden of OUD increased. In China, females, individuals aged 15-24 years, and recent birth cohorts showed higher disease burdens. Over time, the relationship between DALYs and SDI gradually weakened. Projections suggest that the burden of OUD in China is expected to increase over the next 15 years. Conclusion: Opioid misuse is a significant factor contributing to the global disease burden and challenges in anesthetic and surgical care. Effective measures are urgently needed to reduce the burden of opioid dependence and promote advancements in pain-free medical care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.